How is octreotide given (administered)?
Octreotide may be administered as an injection under the skin (subcutaneous), or as an injection into a muscle (intramuscular) and the dose depends on several factors, including the condition being treated, the particular regimen being used, and the overall health of the patient. The depot formulation that is administered intramuscularly remains active for longer in the body, requiring fewer injections, usually monthly. Some patients who are treated with subcutaneous octreotide may be able to administer the injections at home. How are patients monitored? Patients will usually have scheduled meetings and physical exams with their healthcare provider while they are being treated with octreotide. Patients will be monitored for gallstones, or abnormalities of the gallbladder. Patients who experience pain following a meal, particularly a meal that is high in fat, should contact their healthcare provider. Levels of hormones and endocrine function may also be monitored from blood tests. What